SUPT5H Antikörper (C-Term)
Kurzübersicht für SUPT5H Antikörper (C-Term) (ABIN1109175)
Target
Alle SUPT5H Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Sequenz
- PYAAPSPQGS YQPSPSPQSY HQVAPSPAGY QNTHSPASYH PTPSPMAYQA
-
Kreuzreaktivität (Details)
- Species reactivity (expected):Mouse, Rat, Dog, Bovine, African clawed frog, Chicken, ZebrafishSpecies reactivity (tested):Human
-
Aufreinigung
- Purified using peptide immunoaffinity column
-
Immunogen
- The immunogen for anti-SUPT5H antibody: synthetic peptide directed towards the C terminal of human SUPT5H
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Rekonstitution
- Add 50 μL of distilled water to a final concentration of 1 mg/mL.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store lyophilized at 2-8 °C or at -20 °C long term. After reconstitution store the antibody undiluted at 2-8 °C for up to one month or in aliquots at -20 °C long term.
-
-
- SUPT5H (Transcription Elongation Factor SPT5 (SUPT5H))
-
Andere Bezeichnung
- SUPT5H
-
Hintergrund
- SUPT5H and its binding partner regulate transcriptional elongation by RNA polymerase II. SPT4 and SPT5 are involved in both 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)-mediated transcriptional inhibition and the activation of transcriptional elongation by the human immunodeficiency virus type 1 (HIV-1) Tat protein.Synonyms: DRB sensitivity-inducing factor large subunit, DSIF p160, DSIFp160, SPT5, SPT5H, Tat-CT1 protein, Tat-cotransactivator 1 protein, Transcription elongation factor SPT5
-
Gen-ID
- 6829
-
NCBI Accession
- NP_003160
Target
-